NCT02936388 2025-01-24
SirTac
Charite University, Berlin, Germany
Phase 2 Completed
Clinical Trials
7 trialsNCT04903548 2024-11-18
Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC with Y90 SIR-Spheres
Methodist Health System
Completed
NCT04332419 2022-06-22
Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies
Case Comprehensive Cancer Center
Phase NA Completed
NCT01126645 2019-05-31
SORAMIC
University of Magdeburg
Phase 2 Completed
NCT01469572 2018-10-18
Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases
Emory University
Phase 1 Completed
NCT01798160 2015-10-20
Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC).
Johannes Gutenberg University Mainz
Phase 4 Completed
NCT00604409 2015-09-07
Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer
Fox Chase Cancer Center
Phase 1 Completed